In today's world, advancements in technology have made it possible to conduct various tests from the comfort of your home, including DNA testing.
Frequently Asked Questions
What are the limitations and privacy risks of at-home DNA testing?
Important limitations to be aware of. Health risk predictions from consumer DNA tests have modest predictive value for most common diseases (diabetes, heart disease, cancer) — polygenic risk scores are still emerging science, and individual risk from a handful of SNPs is limited. Don't change medical treatment based on consumer DNA reports without discussing them with your doctor. Ancestry reports are estimates based on reference populations — more accurate for European ancestry than South Asian, and regional Indian ancestry (Punjabi, Tamil, Bengali) accuracy is still improving. Some conditions need full gene sequencing (not the SNP panel consumer tests use) — for BRCA1/2, Lynch syndrome, hereditary heart conditions, or monogenic disorders, use hospital-based clinical genetic testing with a genetic counsellor. Privacy risks are real: your data may be stored on foreign servers, shared or sold in aggregate to pharmaceutical companies (opt-out often isn't the default), reveal information about relatives who haven't consented, and be accessed by law enforcement via subpoena. Read consent terms carefully, opt out of research sharing if concerned, and delete raw data from company servers after receiving results if you can.
When is genetic testing genuinely medically valuable — beyond consumer curiosity?
Legitimate clinical uses include: BRCA1/BRCA2 testing for women with strong family history of breast or ovarian cancer (multiple first-degree relatives affected, young-onset cases) — a positive result guides screening intensity and prophylactic surgery decisions; hereditary cancer syndromes like Lynch syndrome and familial adenomatous polyposis — where multiple family members have colorectal or endometrial cancers; carrier screening for cystic fibrosis, thalassemia, and sickle cell disease — important in communities with high carrier frequency, especially before marriage or pregnancy; hereditary heart conditions (long QT syndrome, hypertrophic cardiomyopathy) — where there's family history of sudden cardiac death, early heart attacks, or unexplained arrhythmias; prenatal genetic testing for chromosomal disorders and birth defects (NIPT and amniocentesis); newborn screening for metabolic disorders; pharmacogenomic testing (CYP2C9/VKORC1 for warfarin dosing, TPMT for azathioprine); and rare disease diagnosis after extensive workup fails to identify a cause. All medical genetic testing should involve pretest and post-test genetic counselling — access through medical geneticists at tertiary hospitals or Indian Society of Human Genetics centres.
Questions About This Article
Have a question? Ask the author directly.
Have a question about this article?
Ask Zocvi Editorial directly. Your question may help others with similar concerns.




Comments (0)